ipilimumab
bms
[]
excellent thread from on the historic struggles to get a til therapy to market plus new #esmo22 data on a til product that researchers in the netherlands may try to bring to market w/out pharma involvement 
Journalist: Personalized medicine, genomics, cancer; Managing editor: @PrecOncNews 
https://t.co/gIcH3rwjcu 
@GenomeWeb 
https://t.co/MJTiedX6Di